APA

Schweizer M. T., Wang H., Bivalacqua T. J., Partin A. W., Lim S. J., Chapman C., Abdallah R., Levy O., Bhowmick N. A., Karp J. M., De Marzo A., Isaacs J. T., Brennen W. N. & Denmeade S. R. (20200430). A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer. : Stem cells translational medicine.

Chicago

Schweizer Michael T, Wang Hao, Bivalacqua Trinity J, Partin Alan W, Lim Su Jin, Chapman Carolyn, Abdallah Rehab, Levy Oren, Bhowmick Neil A, Karp Jeffrey M, De Marzo Angelo, Isaacs John T, Brennen W Nathaniel and Denmeade Samuel R. 20200430. A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer. : Stem cells translational medicine.

Harvard

Schweizer M. T., Wang H., Bivalacqua T. J., Partin A. W., Lim S. J., Chapman C., Abdallah R., Levy O., Bhowmick N. A., Karp J. M., De Marzo A., Isaacs J. T., Brennen W. N. and Denmeade S. R. (20200430). A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer. : Stem cells translational medicine.

MLA

Schweizer Michael T, Wang Hao, Bivalacqua Trinity J, Partin Alan W, Lim Su Jin, Chapman Carolyn, Abdallah Rehab, Levy Oren, Bhowmick Neil A, Karp Jeffrey M, De Marzo Angelo, Isaacs John T, Brennen W Nathaniel and Denmeade Samuel R. A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer. : Stem cells translational medicine. 20200430.